Skin Cancer Treatment Journal

Living Longer Isn't Enough Anymore

Medicine spent a century learning how to keep you alive. It's only now starting to ask whether that's enough.

Jul 24 • Adam Lefton

2

June 2026

The Truth Behind Neglected Tumors

Identifying and Removing the Barriers Between Diagnosis and Treatment

Jun 26 • Joshua Swindle

2

It's Time to Retire 3.3 million: A Modern Estimate of the U.S. Skin Cancer Burden

Dermatology has quoted the same nonmelanoma skin cancer numbers for fourteen years. The population they describe no longer exists.

Jun 12 • Adam Lefton

2

May 2026

The Most Common Cancer We Don't Count

Why there is no nonmelanoma skin cancer registry — and why it's time to build one

May 28 • Adam Lefton

When Patient Stories Spark Unexpected Conversations

As Chief Marketing Officer of GentleCure, I’ve had the privilege of helping bring more than half a dozen patient stories to television.

May 9 • Adam Lefton

1

April 2026

Patients Don’t Want a Procedure.

They Want a Cure.

Apr 27 • Scott McKain

1

Making the Case to Preserve SRT

Why a less effective treatment may still have a role to play in the treatment of NMSC

Apr 21 • Adam Lefton

1

Don’t Confuse the Device with the Treatment

GentleCure is Advanced IGSRT

Apr 12 • Adam Lefton

1

Why IGSRT Represents a Meaningful Advancement Over Traditional SRT

If you can see the tumor, measure it, and confirm it’s gone… Why would you treat it blindly?

Apr 11 • Adam Lefton

When Evidence Is Clear, Medicine Must Move Faster

Inertia Has Consequences, Speed Becomes Responsibility

Apr 5 • Adam Lefton

March 2026

Policy and Patient Trust

Trust in healthcare is incredibly fragile

Mar 26 • Scott McKain

3

1

When Doctors Stopped Leading

The Path Back to Trust

Mar 19 • Adam Lefton

2

1